Predict your next investment

Cam Med company logo
HEALTHCARE | Medical Devices & Equipment / Surgical Devices
myevopump.com

See what CB Insights has to offer

Stage

Incubator/Accelerator - III | Alive

Total Raised

$1.7M

About Cam Med

Cam Med is a development stage company applying microfluidics to medical devices. The company is developing a bandage-like patch pump which could greatly improve compliance with challenging medication regimens involving injectable drugs.

Cam Med Headquarter Location

29 Exeter Street

West Newton, Massachusetts, 02465,

United States

617-682-2111

Latest Cam Med News

JDRF, Cam Med to develop flexible patch pump for automated insulin delivery systems

Feb 6, 2018

JDRF, Cam Med to develop flexible patch pump for automated insulin delivery systems Published 06 February 2018 JDRF has collaborated with Cam Med to develop a user-centric insulin pump for next-generation artificial pancreas systems. This funding commitment from JDRF will enable Cam Med to further the development of its innovative Evopump, an ultra-thin and flexible, bandage-like patch pump. Since JDRF launched the Artificial Pancreas Project more than a decade ago, significant progress has been made in automating insulin delivery. However, the bulkiness of  automated insulin delivery devices remains a challenge and may be a factor inhibiting wide-scale adoption, especially in children where skin "real estate" is at a premium. The goal of this collaboration is to accelerate the development of Cam Med's conformable and small-footprint Evopump, which would represent a substantial improvement over existing delivery systems for both pediatric and adult users. JDRF research program scientist Dr Jaime Giraldo said: "JDRF is excited to partner with Cam Med on improving insulin delivery hardware. The Evopump represents the type of miniaturized and user-centric design that could substantially reduce the burden of living with type 1 diabetes and remove obstacles preventing some people, particularly children, from using devices that could improve their glucose management." Cam Med CEO Larry Alberts said: “This partnership with JDRF enables Cam Med to accelerate the development and commercialization of the Evopump, and we're looking forward to it becoming the core delivery platform for future AP systems." T1D is an autoimmune disease that occurs when a person's pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body's immune system. T1D must be managed with the lifelong use of insulin—either via injection or insulin pump. Source: Company Press Release

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cam Med

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cam Med is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

7,870 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Diabetes

1,750 items

Cam Med Patents

Cam Med has filed 2 patents.

The 3 most popular patent topics include:

  • Dosage forms
  • Drug delivery devices
  • Indoles
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/27/2017

9/3/2019

Dosage forms, Drug delivery devices, Fluid dynamics, Medical equipment, Indoles

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/27/2017

00/00/0000

Grant Date

9/3/2019

00/00/0000

Title

Subscribe to see more

Related Topics

Dosage forms, Drug delivery devices, Fluid dynamics, Medical equipment, Indoles

Subscribe to see more

Status

Grant

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.